VOTUBIA

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug VOTUBIA contains one active pharmaceutical ingredient (API):

1	Everolimus UNII 9HW64Q8G6G - EVEROLIMUS
	Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers.
	Read more about Everolimus

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VOTUBIA Tablet	MPI, EU: SmPC	European Medicines Agency (EU)
VOTUBIA Dispersible tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01EG02	Everolimus	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L01EG02
L04AH02	Everolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L04AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1539468, 1539479, 1539480, 1539503, 1539514, 1539525, 1539536, 1633890, 1639548, 1639559, 1639560, 1639571, 1639582, 1639593, 1639605, 1737727, 1774133
ES	Centro de información online de medicamentos de la AEMPS	111710006, 111710010, 111710012, 111710014, 11710002, 11710004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	068276, 138514, 399306, 467959, 549685
FR	Base de données publique des médicaments	60223417, 61063232, 62601043, 64945242, 66520037, 69793977
GB	Medicines & Healthcare Products Regulatory Agency	197111, 197163, 216787, 341649, 341652, 341655
IL	מִשְׂרַד הַבְּרִיאוּת	8314
IT	Agenzia del Farmaco	041397011, 041397023, 041397035, 041397047, 041397050, 041397062, 041397074, 041397086, 041397098, 041397100, 041397112, 041397124, 041397136, 041397148, 041397151, 041397163
LT	Valstybinė vaistų kontrolės tarnyba	1062009, 1062010, 1062011, 1062012, 1062013, 1062014, 1062015, 1071835, 1072760, 1072778, 1072779, 1072780, 1072781, 1072782, 1072783, 1085818
NL	Z-Index G-Standaard, PRK	100471, 113441, 139653, 92568, 92576
PL	Rejestru Produktów Leczniczych	100253844, 100253867, 100253873, 100387645, 100387651, 100387668, 100417228
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64600002, W64601001, W64602001, W64602002, W64603001, W64604001, W64605001